Skip to content
CPCPCP139139139

Drawing based on the label description. No photo yet.

“2.5 mg tablets: dark yellow colored, round biconvex, film-coated tablets with "CP" debossed on one side and "139" on other side”

CP 139 pill

Pill with imprint CP 139 is yellow, round, 7 mm and has been identified as Letrozole 2.5 mg. It is used for breast cancer. It is supplied by Carnegie Pharmaceuticals LLC.

Letrozole 2.5 mg

Imprint
CP 139
Strength
2.5 mg
Used for
Breast cancer
Color
Yellow
Shape
Round
Size
7 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Carnegie Pharmaceuticals LLC
Drug class
Breast cancer medicine (aromatase inhibitor)
NDC
80005-139, 80005-139-08, 80005-139-10

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Letrozole pills and guides

What is Letrozole used for?

Letrozole is used for breast cancer.

Medicine type
Breast cancer medicine (aromatase inhibitor)
Official uses from the US prescribing label

Adjuvant Treatment of Early Breast Cancer

Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Extended Adjuvant Treatment of Early Breast Cancer

Letrozole tablets are indicated for the extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy. The effectiveness of letrozole tablets in extended adjuvant treatment of early breast cancer is based on an analysis of disease-free survival (DFS) in patients treated with letrozole tablets for a median of 60 months.

First and Second-Line Treatment of Advanced Breast Cancer

Letrozole tablets are indicated for first-line treatment of postmenopausal women with hormone receptor positive or unknown, locally advanced or metastatic breast cancer. Letrozole tablets are also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

From the FDA-approved label on DailyMed (published Aug 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows CP and the other side shows 139.
  • It is yellow, round, 7 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Letrozole

Inactive: Silicon Dioxide, Croscarmellose Sodium, Hypromellose 2910 (6 Mpa.s), Lactose Monohydrate, Magnesium Stearate, Polyethylene Glycol 3350, Povidone, Talc, Titanium Dioxide, Ferric Oxide Yellow

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Letrozole pills